Literature DB >> 6965409

Juvenile dermatomyositis: a clinical and immunologic study.

L M Pachman, N Cooke.   

Abstract

Twenty-one children were diagnosed as having juvenile dermatomyositis on the basis of the strict criteria of Bohan and Peter. In addition to the typical skin and muscle changes, abnormalities of esophageal motility (eight of 19), pulmonary function (14 of 17), ECG (10 of 20), and gastrointestinal absorption of D-xylose (two of eight) with active disease were observed. Clinical signs of other collagen vascular disease appeared in five children. Serologic evaluation demonstrated that ANA and rheumatoid factor were transiently positive in six; one child developed a persistently positive rheumatoid factor after four years of disease inactivity. Antibody to ENA was negative in all, but antibody to PM-1 antigen was present in four of 18. Six had a low C3 or C4; evidence of immune complexes was demonstrated by Clq or Raji binding in eight with active disease. One child was IgA deficient. The HLA-B8 antigen was present in 72% of the Caucasian children as compared with the expected incidence of 21%. Therefore, classical dermatomyositis in children has more systemic involvement then previously appreciated, may be related to the presence of circulating immune complexes, and appears to be under immunogenetic control.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965409     DOI: 10.1016/s0022-3476(80)80807-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Juvenile dermatomyositis.

Authors:  V Seth; S K Kabra; O P Semwal; Y Jain
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.

Authors:  Neslihan Edeer Karaca; Guzide Aksu; Betul Sozeri Yeniay; Necil Kutukculer
Journal:  Rheumatol Int       Date:  2006-08-30       Impact factor: 2.631

Review 3.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 4.  Juvenile dermatomyositis.

Authors:  Michelle Batthish; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

5.  Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.

Authors:  Micah J Eimer; Wendy J Brickman; Roopa Seshadri; Rosalind Ramsey-Goldman; David D McPherson; Beverly Smulevitz; Neil J Stone; Lauren M Pachman
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

6.  Anaesthetic management of a child with dermatomyositis.

Authors:  R A Johns; D A Finholt; J A Stirt
Journal:  Can Anaesth Soc J       Date:  1986-01

Review 7.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

8.  Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.

Authors:  A M Hargis; K H Haupt; G A Hegreberg; D J Prieur; M P Moore
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

9.  Drug treatment of juvenile dermatomyositis.

Authors:  G Miller; J Z Heckmatt; V Dubowitz
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

Review 10.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.